Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

PHASE3CompletedINTERVENTIONAL

Enrollment

529

Participants

Timeline

Start Date

August 17, 2004

Primary Completion Date

January 14, 2005

Study Completion Date

January 14, 2005

Conditions

Migraine

Interventions

DRUG

MK0462, rizatriptan benzoate / Duration of Treatment: 1day

DRUG

Comparator: placebo / Duration of Treatment: 1 day

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092963 - Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) | Biotech Hunter | Biotech Hunter